Brackmann Christoph (CIK 2048634) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVCR (55,137 shares), Sell NVCR (6,412 shares), Sell NVCR (7,033 shares), Buy NVCR (10,000 shares), Buy NVCR (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Financial Officer | Buy | 55,137 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chief Financial Officer | Sell | 6,412 | $85,344 |
| 2025-11-04 | NovoCure Ltd (NVCR) | Chief Financial Officer | Sell | 7,033 | $86,014 |
| 2025-07-30 | NovoCure Ltd (NVCR) | Chief Financial Officer | Buy | 10,000 | $116,300 |
| 2025-07-30 | NovoCure Ltd (NVCR) | Chief Financial Officer | Buy | 5,000 | $58,000 |
| 2025-07-30 | NovoCure Ltd (NVCR) | Chief Financial Officer | Buy | 5,000 | $57,500 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05